Transdermal Drug Patches Market Report

Japan Transdermal Drug Patches Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 15, 2019
  • PAGES：211
  • REPORT CODE：GMM243412
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Transdermal Drug Patches market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Transdermal Drug Patches market. Detailed analysis of key players, along with key growth strategies adopted by Transdermal Drug Patches industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Mylan N.V.

    • Boehringer Ingelheim

    • Johnson & Johnson

    • GlaxoSmithKline

    • Hisamitsu Pharmaceutical Co, Inc

    • LTS Lohmann Therapie-Systeme AG

    • Hisamitsu Pharmaceutical Co., Inc.

    • Teikoku Seiyaku

    • UCB

    • Novartis International AG

    • Mylan NV

    • NAL Pharmaceutical Group Limited


    By Type:

    • Fentanyl Transdermal Patch

    • Nicotine Transdermal Patch

    • Buprenorphine Transdermal Patch

    • Clonidine Transdermal Patch

    • Oxybutynin Transdermal Patch

    • Others


    By End-User:

    • Hypertension

    • Contraception

    • Analgesia

    • Smoking Cessation

    • Angina

    • Hormone Replacement

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transdermal Drug Patches Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Transdermal Drug Patches Market Size and Growth Rate of Fentanyl Transdermal Patch from 2014 to 2026

      • 1.3.2 Japan Transdermal Drug Patches Market Size and Growth Rate of Nicotine Transdermal Patch from 2014 to 2026

      • 1.3.3 Japan Transdermal Drug Patches Market Size and Growth Rate of Buprenorphine Transdermal Patch from 2014 to 2026

      • 1.3.4 Japan Transdermal Drug Patches Market Size and Growth Rate of Clonidine Transdermal Patch from 2014 to 2026

      • 1.3.5 Japan Transdermal Drug Patches Market Size and Growth Rate of Oxybutynin Transdermal Patch from 2014 to 2026

      • 1.3.6 Japan Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Transdermal Drug Patches Market Size and Growth Rate of Hypertension from 2014 to 2026

      • 1.4.2 Japan Transdermal Drug Patches Market Size and Growth Rate of Contraception from 2014 to 2026

      • 1.4.3 Japan Transdermal Drug Patches Market Size and Growth Rate of Analgesia from 2014 to 2026

      • 1.4.4 Japan Transdermal Drug Patches Market Size and Growth Rate of Smoking Cessation from 2014 to 2026

      • 1.4.5 Japan Transdermal Drug Patches Market Size and Growth Rate of Angina from 2014 to 2026

      • 1.4.6 Japan Transdermal Drug Patches Market Size and Growth Rate of Hormone Replacement from 2014 to 2026

      • 1.4.7 Japan Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Transdermal Drug Patches Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transdermal Drug Patches by Major Types

      • 3.4.1 Market Size and Growth Rate of Fentanyl Transdermal Patch

      • 3.4.2 Market Size and Growth Rate of Nicotine Transdermal Patch

      • 3.4.3 Market Size and Growth Rate of Buprenorphine Transdermal Patch

      • 3.4.4 Market Size and Growth Rate of Clonidine Transdermal Patch

      • 3.4.5 Market Size and Growth Rate of Oxybutynin Transdermal Patch

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Transdermal Drug Patches Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transdermal Drug Patches by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Transdermal Drug Patches in Hypertension

      • 4.4.2 Market Size and Growth Rate of Transdermal Drug Patches in Contraception

      • 4.4.3 Market Size and Growth Rate of Transdermal Drug Patches in Analgesia

      • 4.4.4 Market Size and Growth Rate of Transdermal Drug Patches in Smoking Cessation

      • 4.4.5 Market Size and Growth Rate of Transdermal Drug Patches in Angina

      • 4.4.6 Market Size and Growth Rate of Transdermal Drug Patches in Hormone Replacement

      • 4.4.7 Market Size and Growth Rate of Transdermal Drug Patches in Others


    5 Market Analysis by Regions

    • 5.1 Japan Transdermal Drug Patches Production Analysis by Regions

    • 5.2 Japan Transdermal Drug Patches Consumption Analysis by Regions


    6 Hokkaido Transdermal Drug Patches Landscape Analysis

    • 6.1 Hokkaido Transdermal Drug Patches Landscape Analysis by Major Types

    • 6.2 Hokkaido Transdermal Drug Patches Landscape Analysis by Major End-Users


    7 Tohoku Transdermal Drug Patches Landscape Analysis

    • 7.1 Tohoku Transdermal Drug Patches Landscape Analysis by Major Types

    • 7.2 Tohoku Transdermal Drug Patches Landscape Analysis by Major End-Users


    8 Kanto Transdermal Drug Patches Landscape Analysis

    • 8.1 Kanto Transdermal Drug Patches Landscape Analysis by Major Types

    • 8.2 Kanto Transdermal Drug Patches Landscape Analysis by Major End-Users


    9 Chubu Transdermal Drug Patches Landscape Analysis

    • 9.1 Chubu Transdermal Drug Patches Landscape Analysis by Major Types

    • 9.2 Chubu Transdermal Drug Patches Landscape Analysis by Major End-Users


    10 Kinki Transdermal Drug Patches Landscape Analysis

    • 10.1 Kinki Transdermal Drug Patches Landscape Analysis by Major Types

    • 10.2 Kinki Transdermal Drug Patches Landscape Analysis by Major End-Users


    11 Chugoku Transdermal Drug Patches Landscape Analysis

    • 11.1 Chugoku Transdermal Drug Patches Landscape Analysis by Major Types

    • 11.2 Chugoku Transdermal Drug Patches Landscape Analysis by Major End-Users


    12 Shikoku Transdermal Drug Patches Landscape Analysis

    • 12.1 Shikoku Transdermal Drug Patches Landscape Analysis by Major Types

    • 12.2 Shikoku Transdermal Drug Patches Landscape Analysis by Major End-Users


    13 Kyushu Transdermal Drug Patches Landscape Analysis

    • 13.1 Kyushu Transdermal Drug Patches Landscape Analysis by Major Types

    • 13.2 Kyushu Transdermal Drug Patches Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Mylan N.V.

      • 14.1.1 Mylan N.V. Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Boehringer Ingelheim

      • 14.2.1 Boehringer Ingelheim Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Hisamitsu Pharmaceutical Co, Inc

      • 14.5.1 Hisamitsu Pharmaceutical Co, Inc Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 LTS Lohmann Therapie-Systeme AG

      • 14.6.1 LTS Lohmann Therapie-Systeme AG Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Hisamitsu Pharmaceutical Co., Inc.

      • 14.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Teikoku Seiyaku

      • 14.8.1 Teikoku Seiyaku Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 UCB

      • 14.9.1 UCB Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Novartis International AG

      • 14.10.1 Novartis International AG Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Mylan NV

      • 14.11.1 Mylan NV Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 NAL Pharmaceutical Group Limited

      • 14.12.1 NAL Pharmaceutical Group Limited Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 149 Figures and 150 Tables)

     

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Fentanyl Transdermal Patch from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Nicotine Transdermal Patch from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Buprenorphine Transdermal Patch from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Clonidine Transdermal Patch from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Oxybutynin Transdermal Patch from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Hypertension from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Contraception from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Analgesia from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Smoking Cessation from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Angina from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Hormone Replacement from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Transdermal Drug Patches Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Transdermal Drug Patches Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Transdermal Drug Patches

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transdermal Drug Patches by Different Types from 2014 to 2026

    • Table Consumption Share of Transdermal Drug Patches by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Fentanyl Transdermal Patch

    • Figure Market Size and Growth Rate of Nicotine Transdermal Patch

    • Figure Market Size and Growth Rate of Buprenorphine Transdermal Patch

    • Figure Market Size and Growth Rate of Clonidine Transdermal Patch

    • Figure Market Size and Growth Rate of Oxybutynin Transdermal Patch

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Transdermal Drug Patches by Different End-Users from 2014 to 2026

    • Table Consumption Share of Transdermal Drug Patches by Different End-Users from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Hypertension from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Contraception from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Analgesia from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Smoking Cessation from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Angina from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Hormone Replacement from 2014 to 2026

    • Figure Japan Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Transdermal Drug Patches Production by Regions

    • Table Japan Transdermal Drug Patches Production Share by Regions

    • Figure Japan Transdermal Drug Patches Production Share by Regions in 2014

    • Figure Japan Transdermal Drug Patches Production Share by Regions in 2018

    • Figure Japan Transdermal Drug Patches Production Share by Regions in 2026

    • Table Japan Transdermal Drug Patches Consumption by Regions

    • Table Japan Transdermal Drug Patches Consumption Share by Regions

    • Figure Japan Transdermal Drug Patches Consumption Share by Regions in 2014

    • Figure Japan Transdermal Drug Patches Consumption Share by Regions in 2018

    • Figure Japan Transdermal Drug Patches Consumption Share by Regions in 2026

    • Table Hokkaido Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Hokkaido Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Hokkaido Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Hokkaido Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Hokkaido Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Hokkaido Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Hokkaido Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Tohoku Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Tohoku Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Tohoku Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Tohoku Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Tohoku Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Tohoku Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Tohoku Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Tohoku Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Kanto Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Kanto Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Kanto Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Kanto Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Kanto Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Kanto Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Kanto Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Kanto Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Kanto Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Chubu Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Chubu Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Chubu Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Chubu Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Chubu Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Chubu Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Chubu Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Chubu Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Chubu Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Kinki Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Kinki Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Kinki Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Kinki Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Kinki Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Kinki Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Kinki Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Kinki Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Kinki Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Chugoku Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Chugoku Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Chugoku Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Chugoku Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Chugoku Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Chugoku Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Chugoku Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Chugoku Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Shikoku Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Shikoku Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Shikoku Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Shikoku Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Shikoku Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Shikoku Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Shikoku Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Shikoku Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Kyushu Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Kyushu Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Transdermal Drug Patches Consumption Share by Types in 2014

    • Figure Kyushu Transdermal Drug Patches Consumption Share by Types in 2018

    • Figure Kyushu Transdermal Drug Patches Consumption Share by Types in 2026

    • Table Kyushu Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Kyushu Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Transdermal Drug Patches Consumption Share by End-Users in 2014

    • Figure Kyushu Transdermal Drug Patches Consumption Share by End-Users in 2018

    • Figure Kyushu Transdermal Drug Patches Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Mylan N.V.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan N.V.

    • Figure Sales and Growth Rate Analysis of Mylan N.V.

    • Figure Revenue and Market Share Analysis of Mylan N.V.

    • Table Product and Service Introduction of Mylan N.V.

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Hisamitsu Pharmaceutical Co, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hisamitsu Pharmaceutical Co, Inc

    • Figure Sales and Growth Rate Analysis of Hisamitsu Pharmaceutical Co, Inc

    • Figure Revenue and Market Share Analysis of Hisamitsu Pharmaceutical Co, Inc

    • Table Product and Service Introduction of Hisamitsu Pharmaceutical Co, Inc

    • Table Company Profile and Development Status of LTS Lohmann Therapie-Systeme AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LTS Lohmann Therapie-Systeme AG

    • Figure Sales and Growth Rate Analysis of LTS Lohmann Therapie-Systeme AG

    • Figure Revenue and Market Share Analysis of LTS Lohmann Therapie-Systeme AG

    • Table Product and Service Introduction of LTS Lohmann Therapie-Systeme AG

    • Table Company Profile and Development Status of Hisamitsu Pharmaceutical Co., Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hisamitsu Pharmaceutical Co., Inc.

    • Figure Sales and Growth Rate Analysis of Hisamitsu Pharmaceutical Co., Inc.

    • Figure Revenue and Market Share Analysis of Hisamitsu Pharmaceutical Co., Inc.

    • Table Product and Service Introduction of Hisamitsu Pharmaceutical Co., Inc.

    • Table Company Profile and Development Status of Teikoku Seiyaku

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teikoku Seiyaku

    • Figure Sales and Growth Rate Analysis of Teikoku Seiyaku

    • Figure Revenue and Market Share Analysis of Teikoku Seiyaku

    • Table Product and Service Introduction of Teikoku Seiyaku

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of Novartis International AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International AG

    • Figure Sales and Growth Rate Analysis of Novartis International AG

    • Figure Revenue and Market Share Analysis of Novartis International AG

    • Table Product and Service Introduction of Novartis International AG

    • Table Company Profile and Development Status of Mylan NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV

    • Figure Sales and Growth Rate Analysis of Mylan NV

    • Figure Revenue and Market Share Analysis of Mylan NV

    • Table Product and Service Introduction of Mylan NV

    • Table Company Profile and Development Status of NAL Pharmaceutical Group Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NAL Pharmaceutical Group Limited

    • Figure Sales and Growth Rate Analysis of NAL Pharmaceutical Group Limited

    • Figure Revenue and Market Share Analysis of NAL Pharmaceutical Group Limited

    • Table Product and Service Introduction of NAL Pharmaceutical Group Limited

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US